Repligen Corporation (RGEN)

167,05 +0,74 (+0,44 %) À la clôture : 04:00PM EDT

Repligen Corporation

Building 1
Suite 100 41 Seyon Street
Waltham, MA 02453
United States
781 250 0111
https://www.repligen.com

Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 1 783

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Anthony J. Hunt	CEO & Director	885k	S.O.	1964
Mr. Olivier Loeillot	President & Chief Commercial Officer	1,49M	S.O.	1970
Mr. Jason K. Garland	CFO & Chief Compliance Officer	282,99k	S.O.	1974
Mr. James R. Bylund	Chief Operating Officer	472,18k	S.O.	1964
Ms. Christine Gebski	Senior Vice President of Filtration & Chromatography	396,09k	S.O.	1968
Mr. Ralf Kuriyel	Senior Vice President of Research & Development	401,74k	S.O.	1958
Mr. Keith Lee Robinson	Chief Information Officer	S.O.	S.O.	S.O.
Ms. Sondra S. Newman	Global Head of Investor Relations	S.O.	S.O.	S.O.
Ms. Kimberly A. Cornwell	General Counsel & Global Head of Legal	S.O.	S.O.	S.O.
Dr. Jaime M. Humara Ph.D.	Senior Vice President of Global Marketing	S.O.	S.O.	S.O.

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Repligen Corporation en date du 1 mai 2024 est 2. Les scores principaux sont Audit : 8; Société : 3; Droits des actionnaires : 1; Compensation : 4.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.